These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34689973)

  • 1. Transfusion Reactions and Adverse Events.
    Abdallah R; Rai H; Panch SR
    Clin Lab Med; 2021 Dec; 41(4):669-696. PubMed ID: 34689973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusion-related adverse reactions: Data from the National Healthcare Safety Network Hemovigilance Module - United States, 2013-2018.
    Kracalik I; Mowla S; Basavaraju SV; Sapiano MRP
    Transfusion; 2021 May; 61(5):1424-1434. PubMed ID: 33880771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion-related errors and associated adverse reactions and blood product wastage as reported to the National Healthcare Safety Network Hemovigilance Module, 2014-2022.
    Chavez Ortiz JL; Griffin I; Kazakova SV; Stewart PB; Kracalik I; Basavaraju SV
    Transfusion; 2024 Apr; 64(4):627-637. PubMed ID: 38476028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digitally enabled hemovigilance allows real time response to transfusion reactions.
    Villamin C; Bates T; Mescher B; Benitez S; Martinez F; Knopfelmacher A; Correa Medina M; Klein K; Dasgupta A; Jaffray DA; Porter C; Tereffe W; Gallardo L; Kelley J
    Transfusion; 2022 May; 62(5):1010-1018. PubMed ID: 35442519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of acute transfusion reactions in a teaching hospital of Sikkim: A hemovigilance initiative.
    Sharma DK; Datta S; Gupta A
    Indian J Pharmacol; 2015; 47(4):370-4. PubMed ID: 26285707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric Hemovigilance and Adverse Transfusion Reactions.
    Sostin N; Hendrickson JE
    Clin Lab Med; 2021 Mar; 41(1):51-67. PubMed ID: 33494885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemovigilance and patient safety: analysis of immediate transfusion reactions in elderly.
    Sobral PADS; Göttems LBD; Santana LA
    Rev Bras Enferm; 2020; 73(suppl 3):e20190735. PubMed ID: 33084830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion-Associated Adverse Events: A Case Report of Nurse Hemovigilance and Recognition of Respiratory Distress.
    Lea NC; Gibbs K; Johnson C; Lam A; Wuestner E; Hui SR
    J Infus Nurs; 2022 Sep-Oct 01; 45(5):264-269. PubMed ID: 36112874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion-Transmitted Infections Reported to the National Healthcare Safety Network Hemovigilance Module.
    Haass KA; Sapiano MRP; Savinkina A; Kuehnert MJ; Basavaraju SV
    Transfus Med Rev; 2019 Apr; 33(2):84-91. PubMed ID: 30930009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion reactions in pediatric compared with adult patients: a look at rate, reaction type, and associated products.
    Oakley FD; Woods M; Arnold S; Young PP
    Transfusion; 2015 Mar; 55(3):563-70. PubMed ID: 25145580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse transfusion reactions and what we can do.
    Wang Y; Rao Q; Li X
    Expert Rev Hematol; 2022 Aug; 15(8):711-726. PubMed ID: 35950450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012.
    Harvey AR; Basavaraju SV; Chung KW; Kuehnert MJ
    Transfusion; 2015 Apr; 55(4):709-18. PubMed ID: 25371300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemovigilance and the Notify Library.
    Whitaker BI; Strong DM; Gandhi MJ; Petrisli E
    Immunohematology; 2017 Dec; 33(4):159-164. PubMed ID: 29378148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analyzing real world data of blood transfusion adverse events: Opportunities and challenges.
    Jhaveri P; Bozkurt S; Moyal A; Belov A; Anderson S; Shan H; Whitaker B; Hernandez-Boussard T
    Transfusion; 2022 May; 62(5):1019-1026. PubMed ID: 35437749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-bank testing for infectious diseases: how safe is blood transfusion?
    Strong DM; Katz L
    Trends Mol Med; 2002 Jul; 8(7):355-8. PubMed ID: 12114117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion-related adverse reactions: From institutional hemovigilance effort to National Hemovigilance program.
    Vasudev R; Sawhney V; Dogra M; Raina TR
    Asian J Transfus Sci; 2016; 10(1):31-6. PubMed ID: 27011667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to mitigate the risk of inducing transfusion-associated adverse reactions.
    Garraud O; Cognasse F; Laradi S; Hamzeh-Cognasse H; Peyrard T; Tissot JD; Fontana S
    Transfus Clin Biol; 2018 Nov; 25(4):262-268. PubMed ID: 30139570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the National Healthcare Safety Network Hemovigilance Module for transfusion-related adverse reactions in the United States.
    Edens C; Haass KA; Cumming M; Osinski A; O'Hearn L; Passanisi K; Eaton L; Visintainer P; Savinkina A; Kuehnert MJ; Basavaraju SV; Andrzejewski C
    Transfusion; 2019 Feb; 59(2):524-533. PubMed ID: 30427540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reactions and complications of blood bank transfusions.
    SANTA CRUZ JZ
    J Philipp Med Assoc; 1947 Jun; 23(6):251-8. PubMed ID: 20265136
    [No Abstract]   [Full Text] [Related]  

  • 20. A Comparison of Transfusion-Related Adverse Reactions Among Apheresis Platelets, Whole Blood-Derived Platelets, and Platelets Subjected to Pathogen Reduction Technology as Reported to the National Healthcare Safety Network Hemovigilance Module.
    Mowla SJ; Kracalik IT; Sapiano MRP; O'Hearn L; Andrzejewski C; Basavaraju SV
    Transfus Med Rev; 2021 Apr; 35(2):78-84. PubMed ID: 33934903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.